TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PETS

PetMed Express Inc

Healthcare · Pharmaceutical Retailers

1.60$ -1.9% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

PetMed Express Inc (PETS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Total Assets" came in at 81 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PETS
Line item 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026
6.3 4.5 4.7 9.0 18 28 43 61 73 82 104 106 91 73 78 83 90 113 135 154 155 187 176 170 170 81
2.9 1.2 3.5 6.4 16 26 40 58 45 62 86 90 88 70 74 80 68 82 105 126 129 161 151 130 94 44
0.3 0.4 0.7 1.0 3.3 13 23 0.3 20 30 53 50 47 18 18 36 38 59 78 101 104 119 111 104 55 21
0.3 0.4 0.7 1.0 3.3 13 23 39 25 30 53 60 57 34 34 51 38 59 78 101 104 119 111 104 55 21
0.2 0.2 0.3 0.7 1.1 1.8 1.2 1.4 1.6 2.9 2.1 2.0 1.6 1.4 1.8 1.9 1.7 1.8 2.3 2.5 3.8 2.6 1.9 1.7 3.3 1.9
1.8 0.6 2.3 4.3 11 11 15 16 18 27 29 25 26 32 36 25 26 20 23 21 18 34 32 19 29 14
1.1 1.5 1.7 1.3 1.5 2.0 1.9 5.1 4.4 3.4 2.6 2.1 1.3 1.6 21 30 29 27 25 25 24 26
0.4 0.4 0.4 0.4 0.4 0.4 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.0 27 27
0.4 0.4 0.4 0.4 0.4 0.4 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 5.9 11 11
4.7 3.7 3.1 3.4 4.5 3.9 5.0 7.4 6.4 7.0 7.3 9.3 9.9 9.2 8.2 7.4 7.1 19 19 20 25 46 34 60 73 52
2.5 3.7 2.8 3.4 4.5 3.9 5.0 7.4 6.4 7.0 7.1 9.0 9.4 9.0 8.1 7.4 7.1 18 18 19 24 45 33 58 72 52
1.0 1.9 0.1 0.1 0.1 0.5 0.5
1.3 1.5 2.7 2.6 3.3 2.7 3.1 5.9 4.4 4.8 4.8 6.5 6.6 6.5 5.8 5.2 5.0 15 15 16 20 40 28 25 37 21
0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1.6 0.8 1.6 5.6 14 24 38 54 67 75 97 97 81 64 70 75 83 93 116 135 130 141 142 110 97 29
-3.0 -5.8 -5.0 -1.7 4.1 12 24 39 59 75 94 97 81 64 69 72 78 87 106 122 126 134 130 92 72 9.3
6.4 9.9 20 21 24 24 24 24 24 23 23 23 21 20 20 20 20 20 20 20 20 20 20 20 20 21

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?